Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2026)

Spero Therapeutics (SPRO) has 10 years of Asset Utilization Ratio data on file, last reported at 0.2 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 56.17% year-over-year to 0.2; the trailing twelve-month figure through Mar 2026 stood at 0.2 (down 56.17% YoY), and the FY2025 full-year result was 0.14, down 57.13% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.2, down from 0.3 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.96 in Q3 2025 and bottomed at 0.13 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.34 (2022), against an average of 0.38.
• The widest annual swing landed in 2022, when Asset Utilization Ratio jumped 338.76%; it then sank 56.17% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.24 in 2022, then surged by 96.64% to 0.47 in 2023, then decreased by 21.98% to 0.37 in 2024, then dropped by 20.33% to 0.3 in 2025, then sank by 33.55% to 0.2 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.2 (Q1 2026), 0.3 (Q4 2025), and 0.96 (Q3 2025), per Business Quant data.

Peer Comparison